Andrew M. Hirsch - Concepedia

Author

Andrew M. Hirsch

McGill University

Also Known As

A M Hirsch, A. M. Hirsch, A.M. HIRSCH, A.M. Hirsch, Andrew M Hirsch, Andrew M. Hirsch, Andrew Michael Hirsch

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

McGill University Jewish General Hospital Western University University of Ottawa University of Toronto

About

Andrew M. Hirsch is an author at McGill University specializing in medicine, public health, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	551
2	Public Health	8	8	286
3	Emergency Medicine	3	3	433
4	Health Sciences	2	2	420
5	Epidemiology	1	1	14

Andrew M. Hirsch

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Functional and Exercise Limitations After a First Episode of Pulmonary Embolism Susan R. Kahn, Andrew M. Hirsch, Arash Akaberi, CHEST Journal Pulmonary EmbolismThrombosisExercise LimitationsVenous ThrombosisExercise	2016	265
Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trial Susan R. Kahn, Ian Shrier, Susan Shapiro, Canadian Medical Association Journal	2010	158
Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort Study Susan R. Kahn, Arash Akaberi, John Granton, The American Journal of Medicine Pulmonary EmbolismPhysical ActivityExerciseExercise PhysiologyElope Cohort Study	2017	155
Diagnostic Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Practice Guideline Sanjay Mehta, Doug Helmersen, Steeve Provencher, Canadian Respiratory Journal	2010	83
Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension David Langleben, Brian W. Christman, Robyn J. Barst, American Heart Journal ThrombosisHypertensionPulmonary Arterial HypertensionPrimary Pulmonary HypertensionCardiovascular Disease	2002	81
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation Grégoire Le Gal, Michael J. Kovacs, Laurent Bertoletti, Annals of Internal Medicine	2021	69
Sustained Symptomatic, Functional, and Hemodynamic Benefit With the Selective Endothelin-A Receptor Antagonist, Sitaxsentan, in Patients With Pulmonary Arterial Hypertension David Langleben, Andrew M. Hirsch, Eileen Shalit, CHEST Journal HypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseaseAntihypertensive Therapy	2004	60
Etiology-Specific Endothelin-1 Clearance in Human Precapillary Pulmonary Hypertension David Langleben, Jocelyn Dupuis, Isaac Langleben, CHEST Journal HypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseaseEtiology-specific Endothelin-1 Clearance	2006	55
Unilateral pulmonary artery thrombotic occlusion: is distal arteriopathy a consequence? Andrew M. Hirsch, K M Moser, William R. Auger, American Journal of Respiratory and Critical Care Medicine ThrombosisPulmonary EmbolismVascular DiseaseVenous ThrombosisCardiovascular Disease	1996	42
Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study Kim A., Susan R. Kahn, Arash Akaberi, Research and Practice in Thrombosis and Haemostasis	2018	42

Page 1